1 | TORRE L A, SIEGEL R L, JEMAL A. Lung cancer statistics[J]. Adv Exp Med Biol, 2016, 893(2): 1-19. |
2 | HIRSCH F R, SCAGLIOTTI G V, MULSHINE J L, et al. Lung cancer: current therapies and new targeted treatments[J]. Lancet, 2017, 389(10066): 299-311. |
3 | 章必成, 朱 波. 晚期非小细胞肺癌化学治疗的现状与未来[J]. 医药导报, 2018, 37(5): 531-535. |
4 | DILMAN V M. Age-associated elevation of hypothalamic, threshold to feedback control, and its role in development, ageine, and disease[J]. Lancet, 1971, 1(7711): 1211-1219. |
5 | ARRIETA O, VARELA-SANTOYO E, SOTO-PEREZ-DE-CELIS E, et al. Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer[J]. BMC Cancer, 2016, 16: 633. |
6 | YAO L, LIU M K, HUANG Y L, et al. Metformin use and lung cancer risk in diabetic patients: a systematic review and meta-analysis[J]. Dis Markers, 2019, 2019: 6230162. |
7 | CHUANG M C, YANG Y H, TSAI Y H, et al. Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: a population-based retrospective cohort study[J]. PLoS One, 2018, 13(1): e0191129. |
8 | YU C X, JIAO Y, XUE J, et al. Metformin sensitizes non-small cell lung cancer cells to an epigallocatechin-3-gallate (EGCG) treatment by suppressing the Nrf2/HO-1 signaling pathway[J]. Int J Biol Sci, 2017, 13(12): 1560-1569. |
9 | 谢建将, 陈敏东, 陈曲海, 等. 二甲双胍对肺癌A549细胞增殖、迁移、侵袭能力及乳酸生成的影响[J]. 肿瘤学杂志, 2018, 24(4): 323-327. |
10 | GUO Q Q, LIU Z Y, JIANG L L, et al. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase[J]. Mol Med Rep, 2016, 13(3): 2590-2596. |
11 | ZHOU X H, LIU S S, LIN X M, et al. Metformin inhibit lung cancer cell growth and invasion in vitro as well as tumor formation in vivo partially by activating PP2A[J]. Med Sci Monit, 2019, 25: 836-846. |
12 | STOROZHUK Y, HOPMANS S N, SANLI T, et al. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK[J]. Br J Cancer, 2013, 108(10): 2021-2032. |
13 | LI L, WANG Y, PENG T, et al. Metformin restores crizotinib sensitivity in crizotinib-resistant human lung cancer cells through inhibition of IGF1-R signaling pathway[J]. Oncotarget, 2016, 7(23): 34442-34452. |
14 | LUO Z, ZHU T, LUO W, et al. Metformin induces apoptotic cytotoxicity depending on AMPK/PKA/GSK-3β-mediated c-FLIPL degradation in non-small cell lung cancer[J]. Cancer Manag Res, 2019, 11: 681-689. |
15 | AHMAD S, KHAN M Y, RAFI Z, et al. Oxidation, glycation and glycoxidation-The vicious cycle and lung cancer[J]. Semin Cancer Biol, 2018, 49: 29-36. |
16 | 杜雯雯,黄建安.基于程序性死亡受体-1及其配体为靶点的肺癌免疫治疗新进展[J].中国实用内科杂志,2019,39(5):403-406. |
17 | DECENSI A, PUNTONI M, GOODWIN P, et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis[J]. Cancer Prev Res (Phila), 2010, 3(11): 1451-1461. |
18 | MALLIK R, CHOWDHURY T A. Metformin in cancer[J]. Diabetes Res Clin Pract, 2018, 143: 409-419. |
19 | 李瑞阳, 林芷伊, 李 晶, 等. 化疗联合二甲双胍治疗前后非小细胞肺癌患者外周血中IGF-1和mTOR表达变化及其疗效分析[J]. 吉林大学学报(医学版), 2020, 46(1): 108-115. |
20 | RADENKOVIC S, KONJEVIC G, JURISIC V, et al. Values of MMP-2 and MMP-9 in tumor tissue of basal-like breast cancer patients[J]. Cell Biochem Biophys, 2014, 68(1): 143-152. |
21 | DONG J Y, PENG H, YANG X L, et al. Metformin mediated microRNA-7 upregulation inhibits growth, migration, and invasion of non-small cell lung cancer A549 cells[J]. Anticancer Drugs, 2020, 31(4): 345-352. |
22 | QIU M, XUE C Y, ZHANG L Y. Piperine alkaloid induces anticancer and apoptotic effects in cisplatin resistant ovarian carcinoma by inducing G2/M phase cell cycle arrest, caspase activation and inhibition of cell migration and PI3K/Akt/GSK3β signalling pathway[J]. J BUON, 2019, 24(6): 2316-2321. |
23 | FU Q F, HUANG Y H, GE C L, et al. SHIP1 inhibits cell growth, migration, and invasion in non?small cell lung cancer through the PI3K/AKT pathway[J]. Oncol Rep, 2019, 41(4): 2337-2350. |
24 | ZHANG L, LIU B H. Sapylin inhibits lung cancer cell proliferation and promotes apoptosis by attenuating PI3K/AKT signaling[J].J Cell Biochem,2019,120(9): 14679-14687. |
25 | 吴爱兵, 黎明春, 麦宗炯, 等. CK2α通过PI3K/Akt/GSK-3β信号通路调控肺腺癌A549细胞的侵袭及迁移[J]. 中国肺癌杂志, 2017, 20(4): 233-238. |
26 | 刘少鹏, 张 琪, 张红梅, 等. 二甲双胍对人结肠癌HT29细胞的抑制作用及可能机制[J]. 福建医科大学学报, 2018, 52(1): 7-11. |